Introduction and Aims: Diabetic nephropathy(DN) is a low grade inflammatory disease trigged by metabolic disorder. Inflammation has played an important role in the early stage of DN pathogenesis. Inflammatory cytokines, such as C-reactive protein (CRP), have contributed to inflammation through binding immunoglobulin G Fc receptors (FcγRs)in the surface of cell. We previously found that the expression of FcγRs with an immunoreceptor tyrosine-based activation motif(ITAM-FcγRs) increased in the kidney of diabetic CRP-Tg mouse induced by STZ. The present study investigated the potential role of ITAM-FcγRs in the early stage of DN.
Methods: Diabetes was induced by streptozotocin in Sprague Dawley(SD) rats for assessment of kidney injury at 2,4,8weeks by real-time PCR, immunohistochemistry and western blot analysis. In vitro, the pathogenic effect of ITAM-FcγRs was investigated using glomerular mesangial cells cultured with high glucose and/or ITAM-FcγRs antibody. Results: ompared with control, urinary albumin excretion was significantly increased in diabetic SD rats at 2,4 and 8 weeks after STZ injection. Diabetic rats developed severe renal inflammation with enhanced infiltration of macrophages and T cells, and upregulation of pro-inflammatory cytokines (IL-1β, TNFα). Enhanced renal inflammation in diabetic rats was associated with upregulation of ITAM-FcγRs(FcγRI and FcγRIII), and over-activation of the nuclear factor κB signalling pathway.In vitro, high glucose significantly upregulated pro-inflammatory cytokines (IL-1β, TNFα) via FcγRI /III. FcγRI /III were induced by high glucose, which further promoted high glucose-mediated renal inflammation. Conclusions: These findings suggested that ITAM-FcγRs(FcγRI /III) may be mediators in the early stage of DN. Enhanced activation of nuclear factor κB signalling pathway may be the mechanism by which ITAM-FcγRs promote renal inflammation under diabetic conditions.
